silver acetate has been researched along with Gall Bladder Diseases in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Argentiere, S; Aureli, F; Bianchessi, S; Cella, C; Cubadda, F; D'Amato, M; De Maglie, M; Lenardi, C; Mattiello, S; Milani, P; Raggi, A; Recordati, C; Scanziani, E | 1 |
1 other study(ies) available for silver acetate and Gall Bladder Diseases
Article | Year |
---|---|
Tissue distribution and acute toxicity of silver after single intravenous administration in mice: nano-specific and size-dependent effects.
Topics: Acetates; Animals; Brain; Chemical and Drug Induced Liver Injury; Citric Acid; Gallbladder Diseases; Hemorrhage; Injections, Intravenous; Kidney; Liver; Lung; Male; Mice, Inbred ICR; Nanoparticles; Necrosis; Particle Size; Povidone; Risk Assessment; Silver; Silver Compounds; Spleen; Tissue Distribution | 2016 |